Core Viewpoint - The company has conducted its second board meeting to discuss and approve various financial reports and management proposals, including the use of idle funds for cash management and the evaluation of risk assessments related to its financial subsidiary. Group 1: Board Meeting Details - The second board meeting of the company was held on August 21, 2025, with all nine directors present, and the meeting was conducted in accordance with legal and regulatory requirements [8][11]. - The board approved the special report on the use of raised funds for the first half of 2025, which complies with relevant regulations [9][10]. Group 2: Financial Management and Reports - The company plans to use up to RMB 220 million of temporarily idle raised funds and RMB 70 million of idle self-owned funds for cash management, ensuring that normal operations and risk controls are maintained [12][14]. - The total amount raised from the initial public offering was RMB 2.87 billion, with a net amount of RMB 2.80 billion after deducting issuance costs [30][47]. - As of June 30, 2025, the balance of the raised funds was RMB 2.15 billion, with specific usage details provided in the report [31][33]. Group 3: Risk Assessment and Governance - The board approved a risk assessment report for the company's financial subsidiary, ensuring that the evaluation of operational qualifications and internal controls was thorough [12][14]. - The company has established a management framework for raised funds, adhering to legal and regulatory standards to prevent misuse [41][62]. Group 4: Upcoming Shareholder Meeting - The company will hold its third extraordinary general meeting on September 10, 2025, allowing for both on-site and online voting [70][72]. - The meeting will address various proposals that have been previously approved by the board and supervisory committee [72][74].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002706 证券简称：良信股份 公告编号：2025-048 根据中国证券监督管理委员会《上市公司募集资金监管规则》《深圳证券交易所上市公司自律监管指引 第1号——主板上市公司规范运作》以及《深圳证券交易所上市公司自律监管指南第2号——公告格式》 的相关规定，公司就2025年半年度募集资金存放与使用情况作如下专项报告： 一、募集资金基本情况 （一）实际募集资金金额、资金到位情况 经中国证券监督管理委员会《关于核准上海良信电器股份有限公司非公开发行股票的批复》（证监许可 [2022]504号）核准，公司非公开发行不超过203,824,730股普通股，由东吴证券受托承销。截至2022年8 月2日，公司实际发行普通股104,001,367股，每股发行价为14.62元，募集资金总额1,520,499,985.54元。 东吴证券扣除含税保荐费用、承销费用人民币15,204,999.86元后，于2022年8月2日分别存入公司开立在 中国工商银行股份有限公司张江科技支行营业厅（账号1001019729006800280）人民币账户及兴业银行 股份有限公司上海淮海支 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 公司代码：603053 公司简称：成都燃气 第一节 重要提示 1.1本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规 划，投资者应当到http://www.sse.com.cn/网站仔细阅读半年度报告全文。 无 第二节 公司基本情况 2.1公司简介 ■ 2.2主要财务数据 单位：元 币种：人民币 1.2本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确性、完整 性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 1.3公司全体董事出席董事会会议。 1.4本半年度报告未经审计。 1.5董事会决议通过的本报告期利润分配预案或公积金转增股本预案 ■ 2.3前10名股东持股情况表 单位: 股 ■ 2.4截至报告期末的优先股股东总数、前10名优先股股东情况表 □适用 √不适用 2.5控股股东或实际控制人变更情况 □适用 √不适用 2.6在半年度报告批准报出日存续的债券情况 □适用 √不适用 第三节 重要事项 公司应当根据重要性原则，说明报告期内公司经营情况的重大变化，以及报告期内发生的对 ...

Core Viewpoint - The company, China Shipbuilding (Handan) Special Gas Co., Ltd., has conducted its second board meeting to discuss various financial and operational matters, including the use of idle funds for cash management and the approval of the 2025 semi-annual report [8][15][22]. Group 1: Company Overview - The company is identified as China Shipbuilding (Handan) Special Gas Co., Ltd. with stock code 688146 [22]. - The company has not made any profit distribution or capital increase from reserves during the reporting period [5]. Group 2: Financial Data - The total amount raised from the initial public offering (IPO) was approximately RMB 2.87 billion, with a net amount of about RMB 2.80 billion after deducting issuance costs [33][49]. - As of June 30, 2025, the balance of the special account for raised funds was approximately RMB 2.15 billion [32]. Group 3: Board Meeting Resolutions - The board approved a special report on the storage and actual use of raised funds for the first half of 2025 [9][24]. - The board also approved a risk assessment report for China Ship Finance Co., Ltd. [11][26]. - The board agreed to use up to RMB 2.2 billion of temporarily idle raised funds and RMB 700 million of idle self-owned funds for cash management [12][48]. Group 4: Cash Management - The company plans to use temporarily idle raised funds for investments in safe and liquid financial products, ensuring that these do not affect the implementation of investment projects [51][59]. - The cash management will be conducted under strict risk control measures, with a focus on maintaining the safety and liquidity of the funds [63]. Group 5: Upcoming Shareholder Meeting - The company will hold its third extraordinary shareholder meeting on September 10, 2025, using a combination of on-site and online voting methods [72][74].

登录新浪财经APP 搜索【信披】查看更多考评等级 成都燃气集团股份有限公司（证券代码：603053）于2025年8月22日召开第三届董事会第十四次会议和 第三届监事会第八次会议，审议通过了《关于使用自有资金进行现金管理额度的议案》。 现金管理基本情况目的：为提高自有资金使用效率和整体收益，降低财务成本，确保公司资金的保值增 值，为公司及股东谋求更多投资回报。金额：每年使用最高不超过人民币10亿元自有资金进行现金管理 （不包含定期存款及大额存单）。授权有效期：自公司第三届董事会第十四次会议审议通过之日起三十 六个月内有效。产品要求：自有资金拟用于购买安全性高、流动性好、风险性低、保本的产品，且该等 投资产品不得用于质押。资金来源：闲置自有资金，资金来源合法合规。实施方式：董事会授权公司总 经理负责决策及实施事项，包括选择合格专业机构作为受托方、明确现金管理产品的金额、期限、选择 产品品种、签署合同及协议等。信息披露：如后续单笔或者累计实际购买现金管理产品的收益达到须予 以披露标准的，公司将及时按要求披露进展情况，除此之外公司将在定期报告中披露报告期内现金管理 产品办理以及相应的损益情况。 风险控制措施遵守审慎投 ...

Core Viewpoint - The company intends to increase the cash management limit for idle self-owned funds to enhance fund utilization efficiency and generate better investment returns for the company and its shareholders [1][4]. Summary by Sections Basic Situation of Cash Management Increase - The purpose of cash management is to improve the efficiency of idle self-owned funds without affecting normal operations, allowing the company and its wholly-owned subsidiaries to increase cash management to enhance fund returns [1]. - The limit for cash management is set at no more than RMB 200 million (including the principal), increasing the total limit to RMB 500 million (including the principal) for the company and its subsidiaries, effective from the date of approval by the shareholders' meeting until May 15, 2026 [1][4]. Investment Product Types - The company plans to invest in low-risk, liquid principal-protected investment products with a maturity of no more than 12 months, including but not limited to time deposits, structured deposits, large certificates of deposit, income certificates, and wealth management products [2]. Implementation Method - After approval by the shareholders' meeting, the management team is authorized to make investment decisions within the set limits and duration, including selecting investment products, determining investment amounts, and signing relevant contracts [2][3]. Source of Funds - The funds used for cash management will come from idle self-owned funds and will not involve bank credit funds [2]. Information Disclosure - The company will fulfill its information disclosure obligations in accordance with relevant regulations [2]. Impact of Cash Management on the Company - The increase in cash management for idle self-owned funds will not affect the company's normal operations and is expected to improve fund utilization efficiency, thereby providing better returns for shareholders [3][4]. Review Procedures and Opinions - The board of directors and the supervisory board have reviewed and approved the proposal to increase the cash management limit, confirming that it will enhance fund efficiency without harming the interests of the company and its shareholders [4][5]. Sponsor Institution's Review Opinion - The sponsor institution has verified that the proposal has been approved by the board and the supervisory board, and it complies with relevant legal and regulatory requirements [5].

Summary of Key Points Core Viewpoint The report provides a detailed account of the fundraising activities and the actual usage of the raised funds by Longxun Semiconductor (Hefei) Co., Ltd. for the first half of 2025, ensuring compliance with relevant regulations and highlighting the management of the funds. Fundraising Overview - The company raised a total of RMB 1,121,301,008.16 through the issuance of 17,314,716 shares at a price of RMB 64.76 per share, with net proceeds amounting to RMB 1,030,280,987.25 after deducting issuance costs of RMB 91,020,020.91 [1][2] - As of June 30, 2025, the balance in the fundraising account was RMB 54,652,144.00, which includes interest income after deducting fees [2][3] Fund Management - The company has established a fundraising management system to ensure proper storage and usage of the funds, adhering to various legal and regulatory requirements [2][4] - A tripartite supervision agreement was signed with the underwriter and banks to clarify the rights and obligations of all parties involved in managing the funds [2][4] Actual Usage of Funds - The company has directly invested RMB 213,822,073.62 in fundraising projects, with RMB 52,888,175.13 being invested during the reporting period [2][7] - There were no changes in the implementation locations or methods for the fundraising projects during the reporting period [3][6] - The company did not use idle funds to temporarily supplement working capital during the reporting period [5][8] Cash Management of Idle Funds - The company approved the use of idle funds for cash management, with a maximum amount of RMB 90,000,000.00 allocated for safe and liquid investment products [5][6] - Specific cash management activities included investments in structured deposits and other financial products, ensuring that these activities do not affect the implementation of fundraising projects [5][6] Project Status and Adjustments - The company has postponed the expected completion dates for certain fundraising projects, including the "HD Video Bridge and Processing Chip Development and Industrialization Project" and the "High-Speed Signal Transmission Chip Development and Industrialization Project" [6][8] - The total amount of funds invested in these projects as of the reporting period was RMB 28,432.36 million, with a completion rate of 27.60% [7][8]

Meeting Overview - The second meeting of the Supervisory Board of Jinkai (Liaoning) Life Science Co., Ltd. was held on August 22, 2025, with all three supervisors present, ensuring a valid meeting [1][2] Financial Reporting - The Supervisory Board reviewed and confirmed that the company's 2025 semi-annual report and its summary were prepared in accordance with relevant laws and regulations, accurately reflecting the company's financial status and operational results without any false records or omissions [1][2] Fund Management - The company adhered to the regulations regarding the management and use of raised funds, confirming that there were no violations in the storage and management of these funds [2][3] - The proposal to change the method of fund allocation from "loaning to subsidiaries" to "capital increase in subsidiaries" was deemed reasonable and beneficial for improving fund utilization efficiency and protecting shareholder interests [2][3] Cash Management - The use of part of the idle raised funds and self-owned funds for cash management was approved, ensuring it would not affect the investment projects or normal operations of the company [3][4] Capital Supplementation - The proposal to use part of the raised excess funds for permanent working capital supplementation was found to comply with regulations and not conflict with the investment plans [4] Corporate Governance - The revision of the company's articles of association was approved, aimed at optimizing governance and protecting the rights of investors, especially minority shareholders [4][5] Subsidiary Investment - The decision to use self-owned funds to increase capital in Kingchem Life Science LLC for the construction of Kingchem Laboratories Inc. was supported, aligning with the company's strategy to enhance international competitiveness and support global customer needs [5]

Core Viewpoint - The company, Shenzhen Water New Materials Co., Ltd., is utilizing part of its idle raised funds and self-owned funds for cash management to enhance fund efficiency and increase returns without affecting its operational projects [1][4]. Fundraising Overview - The total amount raised by the company is approximately RMB 599.99 million, with a net amount of RMB 587.85 million after deducting issuance costs. All funds have been received and stored in a dedicated account [1]. - The company plans to invest the raised funds in projects including the construction of a 45,000-ton special polymer material production facility and a headquarters base along with a synthetic biological materials innovation center [2]. Cash Management Plan - The company intends to use up to RMB 250 million of idle raised funds and RMB 200 million of self-owned funds for cash management, with the authorization valid for 12 months from the board's approval date [2][5]. - The investment products for idle raised funds will be low-risk, high liquidity, with a maturity not exceeding 12 months, including structured deposits and large certificates of deposit [3]. Risk Control Measures - The company will select investment products from reputable and financially stable institutions, continuously monitor the net value changes of these products, and take necessary actions if risks are identified [4]. - The audit department will conduct comprehensive checks on the investment products, and independent directors and the supervisory board will oversee the fund usage [4]. Approval Process - The board of directors and the supervisory board have approved the cash management plan, ensuring it does not affect the company's daily operations or the safety of funds [5][6]. - The cash management plan is within the decision-making authority of the board and does not require shareholder approval [5]. Sponsor's Opinion - The sponsor, Guosen Securities, has confirmed that the cash management plan complies with relevant regulations and has undergone necessary legal procedures [6].

中信建投证券股份有限公司 关于金凯（辽宁）生命科技股份有限公司 使用部分闲置募集资金（含超募资金）及自有资金进行现金 管理的核查意见 中信建投证券股份有限公司（以下简称"中信建投证券"、"保荐人"）为 金凯（辽宁）生命科技股份有限公司（以下简称"金凯生科"、"公司"）首次 公开发行股票并在创业板上市的保荐人及持续督导机构，根据《证券发行上市保 荐业务管理办法》《上市公司募集资金监管规则》《深圳证券交易所创业板股票 上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司 规范运作》等法规的有关规定，对金凯生科使用部分闲置募集资金（含超募资金） 及自有资金进行现金管理事项进行了审慎核查，核查情况如下： 一、募集资金基本情况 根据中国证券监督管理委员会（以下简称"中国证监会"）于 2023 年 5 月 注册的批复》（证监许可〔2023〕1115 号），金凯生科首次向社会公开发行人 民币普通股（A 股）21,508,335.00 股，发行价格为 56.56 元/股，本次发行募集资 金总额为 1,216,511,427.60 元，扣除发行费用 105,767,121.02 元后，募集资金净 额为 1 ...